GE HealthCare Technologies Inc. (GEHC)
Automate Your Wheel Strategy on GEHC
With Tiblio's Option Bot, you can configure your own wheel strategy including GEHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GEHC
- Rev/Share 43.6871
- Book/Share 21.779
- PB 3.5335
- Debt/Equity 1.1033
- CurrentRatio 1.1197
- ROIC 0.082
- MktCap 34287808979.0
- FreeCF/Share 3.4245
- PFCF 21.9091
- PE 15.3149
- Debt/Assets 0.3019
- DivYield 0.0018
- ROE 0.2513
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | GEHC | UBS | Sell | Neutral | -- | $73 | May 5, 2025 |
| Upgrade | GEHC | Goldman | Neutral | Buy | $85 | $100 | March 11, 2025 |
| Upgrade | GEHC | Jefferies | Hold | Buy | $95 | $103 | Jan. 8, 2025 |
| Downgrade | GEHC | UBS | Neutral | Sell | $84 | $74 | Sept. 26, 2024 |
| Upgrade | GEHC | BTIG Research | Neutral | Buy | -- | $100 | Sept. 18, 2024 |
| Initiation | GEHC | JP Morgan | -- | Neutral | -- | $90 | Sept. 9, 2024 |
News
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.
Read More
GEHC or A: Which Is the Better Value Stock Right Now?
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
GE HealthCare (GEHC) Upgraded to Strong Buy: What Does It Mean for the Stock?
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare (GEHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Read More
GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
Published: September 17, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare debuts AI-powered Voluson Performance ultrasound systems, enhancing women's health imaging with faster, smarter diagnostics.
Read More
GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio
Published: September 16, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.
Read More
GE HealthCare Technologies Inc. (GEHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Published: September 09, 2025 by: Seeking Alpha
Sentiment: Neutral
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT Company Participants Peter Arduini - President, CEO & Director Carolynne Borders - Chief Investor Relations Officer Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Presentation Patrick Wood MD of Equity Research Hello, everyone. Thank you so much for joining.
Read More
GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
Published: September 08, 2025 by: Business Wire
Sentiment: Neutral
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare and CDL Nuclear Technologies Group enter agreement to distribute Flyrcado to CDL customer sites around the U.S.
Read More
GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System
Published: September 08, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare's FDA-cleared Revolution Vibe CT promises faster, AI-driven cardiac imaging with improved clarity, boosting efficiency and patient comfort.
Read More
GE HealthCare Technologies Inc. (GEHC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Published: September 04, 2025 by: Seeking Alpha
Sentiment: Neutral
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:45 AM EDT Company Participants James Saccaro - VP & CFO Carolynne Borders - Chief Investor Relations Officer Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst Good morning. I'm Larry Biegelsen, the medical device analyst at Wells Fargo.
Read More
GEHC or A: Which Is the Better Value Stock Right Now?
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of GE HealthCare Technologies (GEHC) and Agilent Technologies (A). But which of these two stocks is more attractive to value investors?
Read More
GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System
Published: September 01, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare's Vivid Pioneer, cleared by CE Mark and FDA, brings AI-powered speed, precision and efficiency to cardiac imaging.
Read More
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
Read More
GEHC Positioned for Growth With AI, Global Expansion and Margins
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare's Q2 results highlight revenue growth, AI-driven innovation, and global expansion with margin gains and strong demand.
Read More
GEHC or A: Which Is the Better Value Stock Right Now?
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
What Makes GE HealthCare (GEHC) a New Strong Buy Stock
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
GEHC vs. BSX: Which Stock Is the Better Value Option?
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.
Read More
GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Neutral
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer James K. Saccaro - VP & CFO Peter J.
Read More
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact
Published: July 30, 2025 by: Investopedia
Sentiment: Positive
GE HealthCare (GEHC) on Wednesday reported better second-quarter results than analysts had expected and lifted its outlook for the full year.
Read More
GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1 per share a year ago.
Read More
GE HealthCare Stock Rises as Earnings Beat. How Tariff Pressures Are Easing.
Published: July 30, 2025 by: Barrons
Sentiment: Positive
Wednesday, GE HealthCare reported earnings per share of $1.06 from sales of just over $5 billion. Wall Street was looking for EPS of 92 cents from sales of just under $5 billion.
Read More
GE HealthCare reports second quarter 2025 financial results
Published: July 30, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We were pleased with solid orders and revenue performance in the second quarter across all segments, reflecting healthy customer investment in capital equipment. We also reported strong earnings performance while leveraging our lean capabilities and demonstrating progress on tariff mitigation. Overall, we believe.
Read More
Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
GEHC leans on Imaging and PDx strength for Q2, but tariff headwinds and margin pressures could test investor confidence.
Read More
GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings
Published: July 24, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), today announced commercial availability of an advanced floor-mounted digital X-ray system, Definium™ Pace Select ET1, designed to deliver high-image quality and optimize efficiency in highly demanding environments while enhancing access and affordability. X-ray exams often serve as the entry point to diagnostic imaging, accounting for 60% of all imaging studies conducted, resulting in an ever-increasing workload for radiologists and techno.
Read More
GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom
Published: July 21, 2025 by: Seeking Alpha
Sentiment: Positive
GE HealthCare Technologies is one of the leaders in the healthcare sector, with a strong position in the global molecular imaging market. GE HealthCare's Pharmaceutical Diagnostics segment's EBIT was $205 million in Q1 2025, up 15.2% year over year. I expect it to rise to $245 million in Q2, driven by increased sales of Vizamyl, which is used to prescribe anti-amyloid drugs for the treatment of Alzheimer's disease.
Read More
3 AI-Driven Medical Device Stocks to Watch in 2025
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
Read More
SNN vs. GEHC: Which Stock Is the Better Value Option?
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and GE HealthCare Technologies (GEHC). But which of these two stocks is more attractive to value investors?
Read More
GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.
Read More
GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's Flyrcado gains momentum with FDA approval, CMS support, and expanding coverage in cardiac PET imaging.
Read More
About GE HealthCare Technologies Inc. (GEHC)
- IPO Date 2022-12-15
- Website https://www.gehealthcare.com
- Industry Medical - Healthcare Information Services
- CEO Peter J. Arduini
- Employees 53000